STEMvision™ for CFU analysis of hematopoietic cell therapy products

Watch the video or view the poster to learn more about: Learn about the CFU assay and its characteristics as a biological tool in assessing hematopoietic stem and progenitor cells. Explore the role of potency assessments at different points in cell and gene therapy workflows. Discover the utility of automated scoring for increased standardization and throughput of the CFU assay.

Dr Colin Hammond works as a Scientist at STEMCELL Technologies, optimizing and developing assay workflows. He has spent 10 years investigating the functional and molecular heterogeneity of human hematopoietic stem and progenitor cells, focusing on the processes of aging, differentiation, and leukemic transformation.

Please enter your email to access content Read now